Abstract
The possibility of using a recombinant fragment of the CagA (128 kDa protein) for the diagnosis ofHelicobacter pylori infection was evaluated. Following cloning of the gene coding for the CagA, a recombinant fragment of it was expressed inEscherichia coli, purified and used in Western blot and an EIA to screen sera from 82 patients with gastroduodenal disease who underwent endoscopic examination. In Western blot, good correlation was found between the serological data obtained with the recombinant antigen and those obtained using non-purified extracts ofHelicobacter pylori. The EIA using the antigen showed a sensitivity of 96.2 % and a specificity of 96.6 % compared with Western blot. These data indicate that the recombinant protein is a reliable antigen for detection of infections withHelicobacter pylori strains that are associated with disease. The EIA assay described may be used in follow-up of the progression of the illness and the results of therapy.
Similar content being viewed by others
References
Warren JR, Marshall B: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, i: 1273–1275.
Blaser MJ: GastricCampylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987, 93: 371–383.
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK:Helicobacter pylori infection and the risk of gastric carcinoma. New England Journal of Medicine 1991, 325: 1127–1131.
Blaser MJ:Helicobacter pylori: its role in disease. Clinical Infectious Diseases 1992, 15: 386–393.
Forman D, Sitas F, Newell DG, Stacey AR, Borcham J, Peto R, Campbell TC, Li J, Chen J: Geographic association ofHelicobacter pylori antibody prevalence and gastric cancer mortality in rural China. International Journal of Cancer 1990, 46: 608–611.
Goodwin CS, Armstrong JA, Childers T, Peters MD, Sly L, McConnell W, Harper WES: Transfer ofCampylobacter pylori andCampylobacter mustelae toHelicobacter gen nov. asHelicobacter pylori comb. nov. andHelicobacter mustelae comb. nov., respectively. International Journal of Systematic Bacteriology 1989, 39: 397–405.
Borromeo M, Lambert JR, Pinkard KJ: Evaluation of “CLO-test” to detectCampylobacter pyloridis in gastric mucosa. Journal of Clinical Pathology 1987, 40: 462–468.
Graham DY, Evans DJ, Alpert LC, Klein PD, Evans DG, Opekun AR, Boutton TW:Campylobacter pylori detected noninvasively by the13C-urea breath test. Lancet 1987, i: 1174–1177.
Bell GD, Weil J, Harrison G, Morden A, Jones PH, Gant PW, Trowell JE, Yoong AK, Daneshmend TK, Logan RFA:14C-urea breath analysis, a non-invasive test forCampylobacter pylori in the stomach. Lancet 1987, i: 1367–1368.
von Wulffen H: An assessment of serological tests for detection ofHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 577–582.
Faulde M, Schroder JP, Sobe D: Serodiagnosis ofHelicobacter pylori infection by detection of immunoglobulin G antibodies using an immunoblot technique and enzyme immunoassay. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 589–594.
Apel I, Jacobs E, Kist M, Bredt W: Antibody response of patients against a 120 kDa surface protein ofCampylobacter pylori. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene (A) 1988, 268: 271–276.
Gerstenecker B, Eschweiler B, Vogele H, Koch HK, Hellerich U, Kist M: Serodiagnosis ofHelicobacter pylori infections with an enzyme immunoassay using the chromatographically purified 120 kilodalton protein. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 595–601.
Cover TL, Dooley CP, Blaser MJ: Characterization of and human serologic response to proteins inHelicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infection and Immunity 1990, 58: 603–610.
Crabtree JE, Figura N, Taylor JD, Bugnoli M, Armellini D, Tompkins DS: Expression of 120 kilodalton protein and cytotoxicity inHelicobacter pylori. Journal of Clinical Pathology 1992, 45: 733–734.
Figura N, Bugnoli M, Cusi MG, Pucci AM, Lusini P, Quaranta S, Barbieri A, Rossolini A, Di Tommaso AL, De Magistris T, Rappuoli R, Marri L, Musmanno RA, Russi M, Guarna M, Losi M: Pathogenic mechanisms ofHelicobacter pylori: production of cytotoxin. In: Malfertheiner P, Ditschuneit H (ed):Helicobacter pylori, gastritis and peptic ulcer. Springer, Berlin, 1990, p. 86–95.
Figura N, Bugnoli M, Guglielmetti P, Musmanno RA, Russi M, Quaranta S: Antibodies to vacuolating toxin ofHelicobacter pylori in dyspeptic patients. In: Pajares JM (ed):Helicobacter pylori and gastroduodenal pathology. Springer, Berlin, 1992, p. 181–186.
Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R: Molecular characterization of the 128-kDa immunodominant antigen ofHelicobacter pylori associated with cytotoxicity and duodenal ulcer. Proceedings of the National Academy of Sciences of the United States of America 1993, 90: 5791–5795.
Olivieri R, Bugnoli M, Armellini D, Bianciardi S, Rappuoli R, Bayeli PF, Abate L, Esposito E, De Gregorio L, Aziz J, Basagni C, Figura N: Growth ofHelicobacter pylori in media containing cyclodextrins. Journal of Clinical Microbiology 1993, 31: 160–162.
Strebel K, Beck E, Strohmaier K, Shaller H: Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. Journal of Virology 1986, 57: 983–991.
Nicosia A, Rappuoli R: Expression and immunological properties of the five subunits of pertussis toxin. Infection and Immunity 1987, 55: 963–967.
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, New York, 1989.
Prior C, Chu V, Holt J, Windisch V, Lee T, Mitschelen J, Newman J, Ricca G, Hrinda M, Tarr C: Production and functional characterization of a recombinant fragment of von Willebrand factor (vWF): an antagonist to platelet receptor GP Ib. Biotechnology 1992, 10: 66–73.
Schaber E, Umlauft F, Stoffler G, Aigner F, Paulweber B, Sandhofer F: Indirect immunofluorescence test and enzyme linked immunosorbent assay for detection ofCampylobacter pylori. Journal of Clinical Microbiology 1989, 27: 327–330.
Dunn BE, Campbell GP, Perez-Perez GL, Blaser MJ: Purification and characterization of urease fromHelicobacter pylori. Journal of Biological Chemistry 1990, 265: 9464–9469.
Goodwin CS, Blincow E, Peterson G, Sanderson C, Cheng W, Marshall B, Warren JR, McCulloch R: Enzymed-linked immunosorbent assay forCampylobacter pyloridis: correlation with presence ofC. pyloridis in the gastric mucosa. Journal of Infectious Diseases 1987, 155: 488–494.
Newell DG, Stacey A: Antigens for the serodiagnosis ofCampylobacter pylori infection. Gastroenterologie Clinique et Biologique 1989, 13: 37B-41B.
Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ:Campylobacter pylori antibodies in humans. Annals of Internal Medicine 1988, 109: 11–17.
Evans DJ, Evans DG, Graham DY, Klein PD: A sensitive and specific serological test for detection ofCampylobacter pylori infection. Gastroenterology 1989, 96: 1004–1008.
Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, Perez-Perez GI, Blaser MJ: Serodiagnosis ofHelicobacter pylori: comparison of enzyme-linked immunosorbent assays. Journal of Clinical Microbiology 1991, 29: 1635–1639.
Talley NJ, Kost L, Haddad A, Zinsmeister AR: Comparison of commercial serological test for detection ofHelicobacter pylori antibodies. Journal of Clinical Microbiology 1992, 30: 3146–3150.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xiang, Z., Bugnoli, M., Ponzetto, A. et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) ofHelicobacter pylori . Eur. J. Clin. Microbiol. Infect. Dis. 12, 739–745 (1993). https://doi.org/10.1007/BF02098460
Issue Date:
DOI: https://doi.org/10.1007/BF02098460